Overexpression FARSB Reveals Poor Prognosis in Breast Cancer and is Correlated with Immunity
FARSB was highly expression at mRNA and protein level in breast cancer. Overexpression of FARSB had a poor prognosis in breast cancer. FARSB expression was associated with immunity and acted as a new target for cancer immunological therapy.
Authors
- Li Tian (ORCID: https://orcid.org/0000-0001-7359-7571)
- Yueming Hu (ORCID: https://orcid.org/0000-0002-7496-887X)
- Bangwei Cao (ORCID: https://orcid.org/0000-0003-0365-036X)
- Jinheng Xu
- Ting Liu (ORCID: https://orcid.org/0000-0002-5824-3975)
Institutions
- Capital Medical University (CN)
- Tangshan People's Hospital (CN)
- Beijing Ditan Hospital (CN)
Publication Details
- Journal
- Cancer Investigation
- Published
- 2025-06-11
- DOI
- https://doi.org/10.1080/07357907.2025.2512379
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00